Percutaneous left atrial appendage device closure has been offered as an alternative to anticoagulation for high‐risk patients with nonvalvular atrial fibrillation. Given the relative novelty of the procedure, we aimed… Click to show full abstract
Percutaneous left atrial appendage device closure has been offered as an alternative to anticoagulation for high‐risk patients with nonvalvular atrial fibrillation. Given the relative novelty of the procedure, we aimed to analyze the rates and causes of immediate (30 days) and short‐term (90 days) readmission after the procedure.
               
Click one of the above tabs to view related content.